Page last updated: 2024-10-29

ketoprofen and Cardiomyopathies

ketoprofen has been researched along with Cardiomyopathies in 1 studies

Ketoprofen: An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis.
ketoprofen : An oxo monocarboxylic acid that consists of propionic acid substituted by a 3-benzoylphenyl group at position 2.

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruynzeel, AM1
Abou El Hassan, MA1
Schalkwijk, C1
Berkhof, J1
Bast, A1
Niessen, HW1
van der Vijgh, WJ1

Other Studies

1 other study available for ketoprofen and Cardiomyopathies

ArticleYear
Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice.
    British journal of cancer, 2007, Mar-26, Volume: 96, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Cardiomyopathies; Dexamethasone; Dox

2007